Hepatitis C virus and immune response;Virus de l'hépatite C et réponse immunitaire

Gastroenterologie Clinique et Biologique

Volumn 25, Issue 4 SUPPL., 2001, Pages

  Pawlotsky, J M ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN;

B LYMPHOCYTE; CELLULAR IMMUNITY; CONFERENCE PAPER; CRYOGLOBULINEMIA; GENETICS; HASHIMOTO DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION CONTROL; NONHODGKIN LYMPHOMA; RISK FACTOR; SALIVARY GLAND DISEASE; T LYMPHOCYTE; VIREMIA;

ANTIBODY FORMATION; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; LIVER;

EID: 0034912894     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (169)

1. T cell-dependent B cell activation
2. The CTL's kiss of death
3. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
4. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes
5. A conditional dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
6. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells
7. CD1 recognition by mouse NK1+ T lymphocytes
8. Role of natural killer and NK1+ T-cells in regulating cell-mediated immunity during Toxoplasma gondii infection
9. Prometheus through the looking glass: Reflections on the hepatic immune system
10. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: Enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis
11. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C
12. Hepatic inflammation and immunity: A summary of a conference on the function of the immune system within the liver
13. Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells
14. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns
15. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome
16. Lack of protective immunity against reinfection with hepatitis C virus
17. Immunity in hepatitis C infection
18. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children
19. Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients
20. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL
21. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons
22. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles
23. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
24. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
25. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus
26. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization
27. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
28. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
29. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures
30. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
31. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment
32. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro
33. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees
34. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies
35. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein
36. Identification of four epitopes in hepatitis C virus core protein
37. Mapping of serotype-specific immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3
38. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody
39. T-lymphocyte response to hepatitis C virus in different clinical courses of infection
40. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
41. The role of cellular immune response in HCV infection
42. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections
43. Compartmentalization of T lymphocytes to the site of disease: Intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C
44. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia
45. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
46. The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C
47. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
48. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
49. Role of the specific T-cell response for clearance and control of hepatitis C virus
50. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection
51. Lymphocyte responses and cytokines
52. Regulation of immunity to parasites by T cells and T cell-derived cytokines
53. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines
54. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein
55. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C
56. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif
57. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection
58. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
59. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome
60. Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein
61. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus
62. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
63. HCV-specific CTL: Evidence for intra-hepatic compartmentalization and participation in disease pathogenesis
64. Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C
65. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
66. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
67. Liver-derived CTL in hepatitis C virus infection: Breadth and specificity of responses in a cohort of persons with chronic infection
68. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
69. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection
70. Analysis of a successful immune response against hepatitis C virus
71. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection
72. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C
73. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release
74. Induction in vitro of a primary human antiviral cytotoxic T cell response
75. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
76. Immunology taught by viruses
77. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
78. Viral mutations, TCR antagonism and escape from the immune response
79. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus
80. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
81. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins
82. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution
83. Hypervariable region I sequence stability during hepatitis C virus replication in chimpanzees
84. No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease
85. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders
86. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European caucasoids
87. Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C
88. MHC class II genes influence the susceptibility to chronic active hepatitis C
89. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients
90. HLA typing in chronic type B, D and C hepatitis
91. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia
92. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
93. Association between MHC class II alleles and clearance of circulating hepatitis C virus
94. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection
95. Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C
96. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C
97. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C
98. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis
99. The pathology of hepatitis C
100. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B
101. Liver biopsy in hepatitis C
102. Ultrastructural features in chronic non-A, non-B (NANB) hepatitis: A controlled blind study
103. Low HCV replication levels in end-stage hepatitis C virus-related liver disease
104. Transgenic expression of hepatitis C virus structural proteins in the mouse
105. The role of immune responses in the pathogenesis of hepatitis C virus infection
106. Cytokines in viral hepatitis
107. Increased frequency of HLA DRI3 in hepatitis C virus carriers with persistently normal ALT levels
108. HLA-DR5 antigen: A genetic factor influencing the outcome of hepatitis C virus infection
109. HLA-DRB1 is related to pathological changes of the liver in chronic hepatitis C
110. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus
111. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C
112. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
113. Natural history of liver fibrosis progression in patients with chronic hepatitis C
114. Independent risk factors for hepatocellular carcinoma in French drinkers
115. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections
116. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
117. Hepatitis C virus infection: Co-infection with HIV and HBV
118. Cryoglobulinémies
119. Hepatitis C virus infection in type II mixed cryoglobulinemia
120. Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspective
121. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage
122. A role for hepatitis C virus infection in type II cryoglobulinemia
123. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype. Implications for the etiopathogenesis and therapy of mixed cryoglobulinemia
124. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection
125. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene
126. Interferon therapy in HCV-positive mixed cryoglobulinaemia: Viral and host factors contributing to efficacy of the therapy
127. Mixed cryoglobulinemia cross-reactive idiotypes: Implications for the relationship of MC to rheumatic and lymphoproliferative diseases
128. HCV infection in B-cell non-Hodgkin's lymphoma
129. HCV and non-Hodgkin lymphoma
130. Hepatitis C virus and non-Hodgkin's lymphomas
131. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders
132. Hepatitis C virus infection: A new bridge between hematologists and gastroenterologists?
133. Clinico-pathological characterization of hepatitis C virus-related B-cell non Hodgkin's lymphomas without symptomatic cryoglobulinemia
134. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
135. HCV and non-Hodgkin lymphoma
136. Non-Hodgkin's lymphoma and hepatitis C virus infection
137. Absence of hepatitis C virus infection in non-Hodgkin's lymphoma
138. HCV and HGV in B-cell non-Hodgkin's lymphoma
139. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center
140. Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma
141. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection
142. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas
143. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
144. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy
145. Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: From virus like particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts
146. Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis
147. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis
148. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: A reappraisal at the light of hepatitis C virus infection
149. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
150. Antibodies to hepatitis C virus in autoimmune liver disease: Evidence for geographical heterogeneity
151. Liver/kidney microsome antibody type 1 and hepatitis C virus infection
152. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis
153. Anti-GOR and hepatitis C virus in autoimmune liver diseases
154. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase
155. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes
156. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera
157. Antibodies to P450IID6, SLA, PDH-E2 and BCKD-E2 in Japanese patients with chronic hepatitis
158. Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients
159. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition
160. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment
161. Serum anti-liver cytosol antibodies type 1 in hepatitis C virus infection
162. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis
163. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: Implication for an autoimmune process
164. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis
165. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection
166. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease
167. Salivary gland lesions in patients with chronic hepatitis C
168. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes
169. Lichen planus and hepatitis C virus-related chronic active hepatitis